[ Price : $8.95]
FDA principal deputy commissioner Joshua Sharfstein says that steroids are the most high profile safety concern facing the dietary...[ Price : $8.95]
FDA issues a second complete response letter this week for a separate BLA for Amgens Prolia (denosumab) and its use treating and p...[ Price : $8.95]
FDA clears a Custom Spine 510(k) for the Pathway AVID (articulating vertebral interbody device).[ Price : $8.95]
GAO says it often has taken FDA many years to complete debarment or disqualification proceedings against clinical investigators wh...[ Price : $8.95]
Consulting editor John Scharmann sees the return of former associate commissioner for regulatory affairs John Taylor III as counse...